EUCR
Eucrates Biomedical Acquisition
EUCR | NASDAQ
Chart Builder DCF Calculator
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET

Eucrates Biomedical Acquisition Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
2.42M 3.48M 3.91M 4.11M 4.77M 3.57M 2.62M 1.99M
– – – – – – – –
– – – – – – – –
– 76.38K 76.38K 140.78K 158.12K 81.74K 81.74K 17.34K
-3.12M -4.32M -4.85M -5.03M -5.69M -4.08M -2.87M -2.12M
– – – – – – – –
68.29K 272.65K 233.35K 214.58K 240.96K 164.59K 81.74K 17.34K
-630.29K -573.19K -705.48K -711.19K -679.12K -345.05K -168.03K -108.01K
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– – – – – – – –
– 250K 250K 250K – – – –
-92.59M 250K 250K 250K – – – –
-30.29K -323.19K -455.48K -461.19K -679.12K -345.05K -168.03K -108.01K
-630.29K -573.19K -705.48K -711.19K -679.12K -345.05K -168.03K -108.01K
-630.29K -573.19K -705.48K -711.19K -679.12K -345.05K -168.03K -108.01K
– – – – – n/a n/a n/a
– – – – – n/a n/a n/a
-630.29K -573.19K -705.48K -711.19K -679.12K n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.